TEAM.NASDAQAtlassian CORP

Form 4: Atlassian Co-CEO Michael Cannon-Brookes Sells Class A Common Stock

Sentiment:

SEC Form 4


Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, executed multiple sales of Class A Common Stock on July 17, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On July 17, 2024, Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, sold shares of Class A Common Stock.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on February 8, 2024.
  • The transactions involved multiple trades at varying prices throughout the day.
  • A total of 8,048 shares were sold at prices ranging from $178.89 to $183.72.
  • The sales were conducted through CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.
  • Following the reported transactions, Cannon-Brookes indirectly owns 413,296 shares through the trust.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating insider trading activity. The sentiment is neutral as it simply reports transactions.

Industry Context

This filing is a routine disclosure of insider trading activity. It is common for executives to use 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information.

Stakeholder Impact

  • The sale of shares by a high-profile executive could have a minor negative impact on shareholder sentiment, although the existence of a pre-arranged trading plan mitigates this concern.

Key Dates

DateDescription
02/08/2024Date of adoption of Rule 10b5-1 trading plan
07/17/2024Date of stock sale transactions
07/18/2024Date of signature on the SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.